Serum Adiponectin but not Leptin at Diagnosis as a Predictor of Breast Cancer Survival |
Lee, Sang-Ah
(Department of Preventive Medicine, Kangwon National University School of Medicine)
Sung, Hyuna (Department of Biomedical Sciences, Seoul National University College of Medicine) Han, Wonshik (Department of Surgery, Seoul National University College of Medicine) Noh, Dong-Young (Department of Surgery, Seoul National University College of Medicine) Ahn, Sei-Hyun (Department of Surgery, University of Ulsan College of Medicine and Asan Medical Center) Kang, Daehee (Department of Biomedical Sciences, Seoul National University College of Medicine) |
1 | Miyoshi Y, Funahashi T, Kihara S, et al (2003). Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res, 9, 5699-704. |
2 | Nkhata KJ, Ray A, Schuster TF, et al (2009). Effects of adiponectin and leptin co-treatment on human breast cancer cell growth. Oncol Rep, 21, 1611-9. |
3 | Oh SW, Park CY, Lee ES, et al (2011). Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study. Breast Cancer Res, 13, 34. |
4 | Ollberding NJ, Kim Y, Shvetsov YB, et al (2013). Prediagnostic leptin, adiponectin, C-reactive protein, and the risk of postmenopausal breast cancer. Cancer Prev Res (Phila), 6, 188-95. DOI |
5 | Pajvani UB, Hawkins M, Combs TP, et al (2004). Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem, 279, 12152-62. DOI |
6 | Petridou E, Papadiamantis Y, Markopoulos C, et al (2000). Leptin and insulin growth factor I in relation to breast cancer (Greece). Cancer Causes Control, 11, 383-8. DOI |
7 | Porter GA, Inglis KM, Wood LA, et al (2006). Effect of obesity on presentation of breast cancer. Ann Surg Oncol, 13, 327-32. DOI ScienceOn |
8 | Ray A, Nkhata KJ, Cleary MP (2007). Effects of leptin on human breast cancer cell lines in relationship to estrogen receptor and HER2 status. Int J Oncol, 30, 1499-509. |
9 | Rock CL, Flatt SW, Laughlin GA, et al (2008). Reproductive steroid hormones and recurrence-free survival in women with a history of breast cancer. Cancer Epidemiol Biomarkers Prev, 17, 614-20. DOI |
10 | Stattin P, Soderberg S, Biessy C, et al (2004). Plasma leptin and breast cancer risk: a prospective study in northern Sweden. Breast Cancer Res Treat, 86, 191-6. DOI ScienceOn |
11 | Stuckey A (2011). Breast cancer: epidemiology and risk factors. Clin Obstet Gynecol, 54, 96-102. DOI |
12 | Sung H, Choi JY, Lee SA, et al (2012). The association between the preoperative serum levels of lipocalin-2 and matrix metalloproteinase-9 (MMP-9) and prognosis of breast cancer. BMC Cancer, 12, 193. DOI |
13 | Sweeney C, Blair CK, Anderson KE, et al (2004). Risk factors for breast cancer in elderly women. Am J Epidemiol, 160, 868-75. DOI ScienceOn |
14 | Tworoger SS, Eliassen AH, Kelesidis T, et al (2007). Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab, 92, 1510-16. DOI |
15 | Vona-Davis L, Rose DP (2007). Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer, 14, 189-206. DOI ScienceOn |
16 | Chen DC, Chung YF, Yeh YT, et al (2006). Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett, 237, 109-14. DOI ScienceOn |
17 | Waki H, Yamauchi T, Kamon J, et al (2003). Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem, 278, 40352-63. DOI ScienceOn |
18 | Wu MH, Chou YC, Chou WY, et al (2009). Circulating levels of leptin, adiposity and breast cancer risk. Br J Cancer, 100, 578-82. DOI ScienceOn |
19 | Brakenhielm E, Veitonmaki N, Cao R, et al (2004). Adiponectininduced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci U S A, 101, 2476-81. DOI ScienceOn |
20 | Cauley JA, Gutai JP, Kuller LH, et al (1989). The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol, 129, 1120-31. |
21 | Cleary MP, Maihle NJ (1997). The role of body mass index in the relative risk of developing premenopausal versus postmenopausal breast cancer. Proc Soc Exp Biol Med, 216, 28-43. DOI |
22 | Fisher FM, Trujillo ME, Hanif W, et al (2005). Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males. Diabetologia, 48, 1084-7. DOI ScienceOn |
23 | Cust AE, Stocks T, Lukanova A, et al (2009). The influence of overweight and insulin resistance on breast cancer risk and tumour stage at diagnosis: a prospective study. Breast Cancer Res Treat, 113, 567-76. DOI |
24 | Dieudonne MN, Bussiere M, Dos Santos E, et al (2006). Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem Biophys Res Commun, 345, 271-9. DOI ScienceOn |
25 | Dieudonne MN, Machinal-Quelin F, Serazin-Leroy V, et al (2002). Leptin mediates a proliferative response in human MCF7 breast cancer cells. Biochem Biophys Res Commun, 293, 622-8. DOI ScienceOn |
26 | Fontana L, Eagon JC, Trujillo ME, et al (2007). Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes, 56, 1010-3. DOI ScienceOn |
27 | Frankenberry KA, Skinner H, Somasundar P, et al (2006). Leptin receptor expression and cell signaling in breast cancer. Int J Oncol, 28, 985-93. |
28 | Gadgil A, Roy N, Sankaranarayanan R, et al (2012). Effect of comprehensive breast care on breast cancer outcomes: a community hospital based study from Mumbai, India. Asian Pac J Cancer Prev, 13, 1105-9. 과학기술학회마을 DOI |
29 | Gaudet MM, Falk RT, Gierach GL, et al (2010). Do adipokines underlie the association between known risk factors and breast cancer among a cohort of United States women? Cancer Epidemiol, 34, 580-6. DOI |
30 | Goodwin PJ, Ennis M, Fantus IG, et al (2005). Is leptin a mediator of adverse prognostic effects of obesity in breast cancer? J Clin Oncol, 23, 6037-42. DOI |
31 | Gross AL, Newschaffer CJ, Hoffman-Bolton J, et al (2013). Adipocytokines, inflammation, and breast cancer risk in postmenopausal women: a prospective study. Cancer Epidemiol Biomarkers Prev, 22, 1319-24. DOI |
32 | Gulcelik MA, Colakoglu K, Dincer H, et al (2012). Associations between adiponectin and two different cancers: breast and colon. Asian Pac J Cancer Prev, 13, 395-8. 과학기술학회마을 DOI ScienceOn |
33 | Haghighat S, Akbari ME, Ghaffari S, et al (2012). Standardized breast cancer mortality rate compared to the general female population of Iran. Asian Pac J Cancer Prev, 13, 5525-8. 과학기술학회마을 DOI ScienceOn |
34 | Harris HR, Tworoger SS, Hankinson SE, et al (2011). Plasma leptin levels and risk of breast cancer in premenopausal women. Cancer Prev Res, 4, 1449-56. DOI |
35 | Hou WK, Xu YX, Yu T, et al (2007). Adipocytokines and breast cancer risk. Chin Med J, 120, 1592-6. |
36 | Hu X, Juneja SC, Maihle NJ, et al (2002). Leptin--a growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst, 94, 1704-11. DOI ScienceOn |
37 | Jarde T, Caldefie-Chezet F, Goncalves-Mendes N, et al (2009). Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies. Endocr Relat Cancer, 16, 1197-210. DOI |
38 | Karimi N, Roshan VD (2013). Change in adiponectin and oxidative stress after modifiable lifestyle interventions in breast cancer cases. Asian Pac J Cancer Prev, 14, 2845-50. 과학기술학회마을 DOI |
39 | Llanos AA, Dumitrescu RG, Marian C, et al (2012). Adipokines in plasma and breast tissues: associations with breast cancer risk factors. Cancer Epidemiol Biomarkers Prev, 21, 1745-55. DOI ScienceOn |
40 | Lee JJ, Park HY (2009). The timing of recurrence dependent on menopausal status after surgery for breast cancer. J Korean Surg Soc, 77, 75-81. 과학기술학회마을 DOI |
41 | Loi S, Milne RL, Friedlander ML, et al (2005). Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev, 14, 1686-91. DOI ScienceOn |
42 | Mantzoros C, Petridou E, Dessypris N, et al (2004). Adiponectin and breast cancer risk. J Clin Endocrinol Metab, 89, 1102-7. DOI ScienceOn |
43 | Mantzoros CS, Bolhke K, Moschos S, et al (1999). Leptin in relation to carcinoma in situ of the breast: a study of premenopausal cases and controls. Int J Cancer, 80, 523-6. DOI |
44 | McTiernan A (2005). Obesity and cancer: the risks, science, and potential management strategies. Oncology, 19, 871-81. |
45 | Maccio A, Madeddu C (2011). Obesity, inflammation, and postmenopausal breast cancer: therapeutic implications. ScientificWorldJournal, 11, 2020-36. DOI |
![]() |